conferenceseries.com Conference Series - America One Commerce Center-1201, Orange St. #600, Wilmington, Zip 19899, Delaware, USA Toll Free: 1-888-843-8169, P: 702-508-5200, F: +1-650-618-1417 Conference Series - UK Kemp House, 152 City Road, London EC1V 2NX, UK Toll Free: +0-800-014-8923 Scientific Program 1290 th Conference October 05-06, 2017 London, UK 9 th International Conference on Leukemia and Hematologic Oncology
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
conferenceseries.com
Conference Series - AmericaOne Commerce Center-1201, Orange St. #600, Wilmington, Zip 19899, Delaware, USA
Toll Free: 1-888-843-8169, P: 702-508-5200, F: +1-650-618-1417
Conference Series - UKKemp House, 152 City Road, London EC1V 2NX, UK
Toll Free: +0-800-014-8923
Scientific Program1290th Conference
October 05-06, 2017 London, UK
9th International Conference on
Leukemia and Hematologic Oncology
Page 2
09:00-09:30 RegistrationsDay 1 October 05, 2017
Keynote ForumIntroduction
09:45-10:30Title: Targeting MCL1-dependant cancers by CDK9 inhibitionDavid J. Bearss, Tolero Pharmaceuticals Inc., USA
10:30-11:15Title: Targeting novel kinases in hematological malignanciesSteven L. Warner, Tolero Pharmaceuticals Inc., USA
Networking and Refreshments Break@ Breakout Areas 11:15-11:30Special session
11:30-12:15
Title: Extension of 2016 World Health Organization (WHO) classification into a new set of clinical, laboratory, molecular, and pathological criteria for the diagnosis of myeloproliferative neoplasms: from Dameshek to Vainchenker, Green and KralovicsJan Jacques Michiels, Goodheart Institute, Netherlands.
Symposium
12:15-13:00Title: Variations in ALL responses to Daunorubicin exist independently of genetic variation in the ATM gene.Hussain M Al-Aamri, Latrobe Univesity, Australia
Lunch Break @RBG 13:00-14:00Sessions: Leukemia | Hematologic Oncology | Blood Disorders and Blood OncologySession Chair: Omnia K. ElGebaly, Cairo University, Egypt
Session Introduction
14:00-14:25Title: Screening and identification of microRNA related with prognosis in patients with extranodal NK/T lymphomasFeng Xiaoli, China
14:25-14:50Title: Modelling human point mutation diseases in Xenopus tropicalis with a modified CRISPR/Cas9 systemYonglong Chen, Southern University of Science and Technology, China
14:50-15:15Title: Vitamin D gene polymorphism in multiple myeloma, chronic lymphocytic leukemia and chronic myeloid leukemiaAnil Tombak, Mersin University Medical Faculty, Turkey
15:15-15:40Title: mTOR expression in acute lymphoblastic leukemia: Possible contribution of mTOR in predicting response to induction chemotherapyAsheema Khanna, National Institute of Pathology, India
Networking and Refreshments Break @ Breakout Areas 15:40-15:55
15:55-16:20
Title: Translation of WHO into improved clinical, laboratory, molecular and pathological (CLMP) criteria for the diagnoses of JAK2 trilinear myeloproliferative neoplasm, MPL thrombocythemia and CALR thrombocythemia and myelofibrosis: From Dameshek to Vainchenker Green, Kralovics and SkodaJan Jacques Michiels, Goodheart Institute, Netherlands
16:20-16:45Title: Prognostic significance of progenitor cell markers CD34/CD38 expression in acute myeloid leukemia egyptian patientsOmnia K. ElGebaly, Cairo University, Egypt
Panel Discussion
Opening Ceremony09:30 - 09:45conferenceseries.com
Armstrong
Page 3
Day 2 October 06, 2017Armstrong
Keynote Forum
10:00-10:45
Title: Sticky platelet syndrome and MPN disease burden in JAK2 Thrombocythemia and Polycythemia Vera, and in JAK2, MPL and CALR Thrombocythemias: Implications for novel non-leukemogenic treatment options in prefibrotic Myeloproliferative Neoplasms anno 2018Jan Jacques Michiels, Goodheart Institute, Netherlands
Special Session
10:45:11:15Title: Clinicopathological study of coagulation profile in non-haematological malignanciesSushma belurkar, Manipal University, India
Networking and Refreshments Break @Breakout Areas 11:15-11:30Sessions: Pediatric hematologist/oncologist | Leukemia Risk factors | Hemato Immunology &Stem Cell Research | Leukemia ImmunologySession Chair: Steven L. Warner, Tolero Pharmaceuticals Inc., USA
Session Introduction
11:30-11:55Title: Glutathione is key to the synergistic enhancement of doxorubicin and etoposide by polyphenols in leukaemia cell lines.Mahbub Amani A, Umm Al Qura University, Saudi Arabia
11:55-12:20Title: Role of ROS, DNA repair, and apoptosis to daunorubicin chemotherapy of Acute lymphoblastic leukaemiaHussain M Al-Aamri, Latrobe Univesity, Australia
12:20-12:45Title: S100A4 protein regulates cell trafficking in B-Cell Lymphomas.Zamzam Amutairi, United Kingdom
Lunch Break@ RBG 12:45-13:30
13:30-13:55Title: Dietary polyphenols influence antimetabolite agents: Methotrexate, 6-Mercaptopurine and 5-Fluorouracil in leukemia cell lines.Mahbub Amani A, Umm Al Qura University, Saudi Arabia
13:55-14:20Title: Acute myeloid leukemia detection in WBC cell based on ICA feature extractionJasvir Kaur, IK Gujral Punjab Technical University, India
14:20-14:45Title: New opportunities in hematologic malignancy treatment: therapeutic application of PI3K inhibitorsAva Safaroghli-Azar, Hahid Beheshti University of medical sciences, Iran
14:45-15:10
Title: The addition of immunotherapy to chemotherapy in the treatment of diffuse large B-cell lymphoma: Retrospective comparison of CHOP versus R-CHOP regimens in Egyptian patients. Usama Elnagar, Saudi Arabia
15:10-15:35Title: Demographics and symptom burden of philadelphia negative myeloproliferative neoplasms in SudanSahar, University of Medical Science and Technology, Sudan
15:35-16:00Title: Effectiveness of P.N.D in prevention of major beta thalassemia in south of Iran.Abdolreza Afrasiabi, Shiraz University of Medical Sciences, Iran
Networking and Refreshments Break 16:00-16:15 @ Breakout AreasPanel Discussion
Awards & Closing Ceremony
Related Documents
